Autopsy report · NCT01965782

A Study of [14C]-LY3023703 in Healthy Participants

“Due to safety results from another trial of LY3023703. No participants in this study received study drug.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 0 months before it stopped.
• 18 participants enrolled.
• Results were posted on the registry 4 years 9 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Eli Lilly and Company

Sponsor type

Industry

Conditions

Healthy Volunteers

Interventions

[^14C]-LY3023703

Participants

18

Sites

1

Countries

United States

Trials that died the same way

• A Safety and Efficacy Study of LYS-GM101 Gene Therapy in Patients With GM1 Gangliosidosis
  “The clinical trial is closed due to Lysogene's cessation of activities. This study closure is not due to safety reasons.” (66% match in meaning)
• Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset
  “Lack of efficacy of the drug; no safety concern” (62% match in meaning)
• Real-time Intraoperative Breast Cancer Visualization for Margin Assessment
  “Before LS301's licensing and reformulation, 9 patients received LS301-HSA (Phase 1a) , but since no patients were recruited (in Phase 1b) before the product expired, this study has been terminated.” (62% match in meaning)
• Iontophoresis in Psoriasis
  “FDA did not provide approval of the use of the drug for the study” (61% match in meaning)
• A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Hematologic Malignancies (MK-8628-005)
  “This study was terminated due to limited efficacy and not due to safety reasons” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.